Galera Therapeutics, Inc.

Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419…

Biotechnology

US, Malvern [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Mergers & Acquisitions Beta

M&As

GRTX M&As
Biotechnology M&A

M&A Deals · Breakdown

Galera Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Galera Therapeutics, Inc. has no acquisition track records yet.